Prestige Consumer Healthcare Inc

PBH: XNYS (USA)
View Stock Summary
Morningstar Rating for Stocks Fair Value Economic Moat Capital Allocation
VmtLOCK|&Ty$LOCK|!$<#&#

Prestige Earnings: Clear Eyes Recovery Gradually Coming Into View

Prestige reported fiscal third-quarter revenue of $283.4 million, down 2.4% year over year, and adjusted EPS of $1.14. Shares fell 2% as management guided full-year results toward the lower end of its prior range, projecting revenue of approximately $1.1 billion and adjusted EPS of $4.54.

Sponsor Center